期刊文献+

重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白对肺间质病变大鼠TGF—β1表达的影响 被引量:1

Effect of recombinant human tumor necrosis factor receptor-Fc fusion protein on the expression of transforming growth factor-β1 in interstitial lung disease of rats
原文传递
导出
摘要 目的观察重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白(rhTNFR—Fc,益赛普)对博来霉素(BLM)-A5所致肺间质病变大鼠转化生长因子(TGF)-β1表达的影响。方法SD雄性大鼠45只,随机分为对照组、模型组和rhTNFR—Fc治疗组(治疗组),每组15只。各组动物于第7、14、28天随机处死5只,取肺组织进行苏木素-伊红(HE)和Masson染色,用免疫组织化学法检测肺组织TGF-β1的表达水平。结果对照组未见明显胶原沉积、炎症及纤维化改变,治疗组各时期肺泡炎和肺纤维化程度均较模型组轻,差异有统计学意义(P〈0.01)。模型组各时期TGF—β1的表达较对照组增加,差异有统计学意义(P〈0.01);治疗组第7、14天TGF—β1的表达较对照组增加,差异有统计学意义(P〈0.01),第28天稍高于对照组,但差异无统计学意义(P〉0.05)。治疗组第7天比模型组减低,差异有统计学意义(P〈0.05),第14、28天比模型组减低差异有统计学意义(P〈0.01)。结论rhTNFR—Fc能减轻BLM—A5诱导的大鼠肺泡炎和肺纤维化,可能与抑制肺组织TGF—β1表达有关。 Objective To observe the effect of recombinant human tumor necrosis factor receptor-Fc fusion protein (rhTNFR-Fc, etanercept) on the expression of transforming growth factor-β1 (TGF-β1) in bleomycin induced interstitial lung disease of rats. Methods Forty-five male Sprague-Dawley (SD) rats were randomly divided into three groups (control group, model group and rhTNFR-Fc treatment group, 15 rats in each), on the 7th, 14th and 28th days, five rats of each group were killed. The lungs were incised to make pathological sections which were stained with HE and Masson, and the expression of TGF-β1 was detected by immunohistochemical technique. Results There was no collagen deposition, alveolitis and fibrosis changes in the control group. The alveolitis and fibrosis of the treatment group was less severe than that in the model group (P〈0.01). The expression of TGF-β1 in the model group was significantly higher than that in the control group (P〈0.01). In the 7th and 14th days, the expression of TGF-β1 in the treatment group was significantly higher than that in the control group (P〈0.01). Although that in the 28th day was a slightly higher but no statistical significance (P〉0.05) could be detected. In the treatment group, the expression of TGF-β1 was lower in the 7th day (P〉0.05) and was significantly lower in the 14th and 28th days than that in the model group (P〈0.01). Conclusion Recombinant human tumor necrosis factor receptor-Fc fusion protein can alleviate the severity of alveolitis and pulmonary fibrosis induced by Bleomycin-A5 in rats, which may be due to the inhibition of TGF-β1 overexpression.
出处 《中华风湿病学杂志》 CAS CSCD 2008年第11期754-756,I0002,共4页 Chinese Journal of Rheumatology
关键词 肺疾病 间质性 博来霉素 受体 肿瘤坏死因子 Ⅱ型 转化生长因子Β1 Lung disease, interstitial Bleomycin Receptor, tumor necrosis factor, type Ⅱ Transforming growth factor beta
  • 相关文献

参考文献14

  • 1杨瑞红,何权瀛,栗占国.风湿病相关性间质性肺病临床特点及治疗分析[J].中华风湿病学杂志,2007,11(12):736-738. 被引量:9
  • 2Inoue K, Takano H, Yanagisawa R, et al. Effects of tumor necrosis factor-α inhibitors on lung lesions with rheumatoid arthritis. Chest, 2003, 124: 413. 被引量:1
  • 3Tengstrand B, Emestam S, Engvall IL, et al. TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis. Lakartidningen, 2005, 102: 3788-3790, 3793. 被引量:1
  • 4Usuki J, Fukuda Y. Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats. Pathol Int, 1995, 45: 552- 564. 被引量:1
  • 5Szapiel SV, Elson NA, Fulmer JD, et al. Bleomycin induced interstitial pulmonary disease in the nude, athyrnic mouse. Am Rev Respir Dis, 1979, 120: 893-897. 被引量:1
  • 6Oikonomou N, Harokopos V, Zalevsky .1, et al. Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS ONE, 2006, 1: e108. 被引量:1
  • 7Bartram U,Speer CP. The role of transforming growth factor β in lung development and disease. Chest, 2004, 125: 754-765. 被引量:1
  • 8Vassallo R, Matteson E, Thomas CF. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition. Chest, 2002, 122: 1093-1096. 被引量:1
  • 9Amano K. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy. Intern Med, 2006, 45: 991-992. 被引量:1
  • 10Mutlu GM, Mutlu EA, Bellmeyer A, et al. Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy. Am J Med, 2006, 119: 639-646. 被引量:1

二级参考文献10

  • 1宋玉,苏新明,李振华,康健,于润江.结缔组织病患者肺功能降低相关因素的探讨[J].中华风湿病学杂志,2004,8(9):519-521. 被引量:4
  • 2李勇,赵秀梅,林江涛.161例结缔组织病患者肺功能分析[J].中日友好医院学报,2004,18(5):284-286. 被引量:2
  • 3高惠英,李小峰.结缔组织病所致间质性肺疾病的研究进展[J].国际呼吸杂志,2007,27(9):673-675. 被引量:12
  • 4American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med, 2002, 165: 277-304. 被引量:1
  • 5Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med, 2004, 25: 549-559. 被引量:1
  • 6Afehra A, Zennaro D, Garzia P, et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol, 2006, 35: 388-394, 被引量:1
  • 7Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics, 2002, 22: S151-S165. 被引量:1
  • 8Watters LC, Schwarz MI, Chemiack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis, 1987, 135: 696-704. 被引量:1
  • 9Kowal-Bielecka O, Kowal K, Rojewska J, et al. Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations. Ann Rheum Dis, 2005, 64: 1343-1346. 被引量:1
  • 10郑捷,潘萌,丁晓毅,邓伟吾.应用一氧化碳弥散功能检测结缔组织病患者肺间质病变的意义[J].中华结核和呼吸杂志,2002,25(7):396-398. 被引量:33

共引文献8

同被引文献14

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部